MabThera (rituximab) chemotherapy drug used to treat lymphomas, leukaemias, transplant rejection and some autoimmune disorders. This chimeric monoclon

---

MabThera (rituximab) chemotherapy drug used to treat lymphomas, leukaemias, transplant rejection and some autoimmune disorders. This chimeric monoclonal antibody is a cytotoxic drug because it destroys B cells with CD20 on their surface, causing cell death.

---

Size: 3496px × 5029px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: anti-cancer, arthritis, autoimmune, cancer, cell, chemotherapy, condition, cytotoxic, death, disease, disorder, drug, hand, healthcare, held, holding, leukaemia, leukemia, lymphoma, mabthera, medical, medicine, oncology, people, person, pharmaceutical, rejection, rheumatoid, rituximab, transplant, treat, treatment